Agenus | AGEN - Dochód Netto





Dochód Netto Zmiana Data
AbbVie USD 695M 1.12B 2026-03
Agenus USD -10.63M 74.49M 2025-12
Amgen USD 1.82B 486M 2026-03
AstraZeneca USD 3.08B 754M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Celldex Therapeutics USD -78.68M 2.63M 2026-03
CSL USD 401M 96.5M 2025-12
Eli Lilly USD 7.4B 760M 2026-03
Gilead Sciences USD 2.02B 162M 2026-03
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Glaxosmithkline GBP 846.06M 1.87B 2025-12
Incyte USD 303.33M 4.05M 2026-03
J&J USD 5.24B 119M 2026-03
Jiangsu Hengrui CNY 2.28B 322.38M 2026-03
Karyopharm Therapeutics USD -102.2M 71.42M 2025-12
MacroGenics USD -14.16M 30.98M 2025-12
Merck EUR 659M 340M 2026-03
Merck USD -4.24B 7.2B 2026-03
Northwest Biotherapeutics USD -27.18M 7.81M 2025-09
Novartis USD 3.16B 747M 2026-03
Novavax USD 17.53M 219.91M 2025-12
Pfizer USD 2.69B 4.34B 2026-03
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Veracyte USD 28.71M 12.44M 2026-03